EU approves Abbott's $25B acquisition of St. Jude Medical with divestiture conditions

The European Commission approved Abbott Laboratories' $25 billion cash-and-stock acquisition of St. Jude Medical, conditional on Abbott divesting two devices used in cardiovascular treatments.

“The European Commission said Wednesday it had given the green light to Abbott Laboratories' $25 billion cash-and-stock acquisition of device maker St. Jude Medical.”law360.com

• 3 sources
• law360.comEU OKs Abbott's $25B Acquisition Of St. Jude With Caveats - Law360Eric KrohNov 23, 2016
• law360.comAbbott To Wrap Up $25B St. Jude Buy With FTC's Approval - Law360Joyce HansonJan 3, 2017
• cardiacrhythmnews.comAbbott completes the acquisition of St Jude Medical - Cardiac Rhythm NewsAngela O'NeillJan 5, 2017

Summarized from public sources; check the original articles before acting on it.